November 17, 2026 earnings date: Cosmos Health stock sits 70.94 percent below its high

Published on 10/17/2026 at 19:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On October 16, 2026, market value was USD 33.3 million. Cosmos Health stock last traded USD 0.33 that day, down 1.52 percent versus Nasdaq prior close.

Scheduled date and valuation

Cosmos Health's next earnings report is scheduled for November 17, 2026.
The 52-week range was USD 0.16 to USD 1.14.
Cosmos Health stock was last at USD 0.33 on October 16, 2026 at 4:00 p.m. ET, down 1.52 percent versus the Nasdaq prior close of October 15, 2026.
The trailing price-to-earnings ratio was minus 0.50.

COSM, US2214133058, Illustration mit AI erstellt.

Cosmos Health (ISIN US2214133058) has its next earnings report scheduled for November 17, 2026, according to Investing.com. The date gives investors a defined checkpoint for the company's next quarterly update. The last Nasdaq quote was USD 0.33 on October 16, 2026 at 4:00 p.m. ET, down 1.52 percent versus the Nasdaq prior close of October 15, 2026 (USD 0.34).

Range and recent trading

Cosmos Health's 52-week range stood at USD 0.16 to USD 1.14 on October 16, 2026. The latest price was 70.94 percent below the high, calculated from USD 0.3313 against USD 1.14. That places the stock closer to its yearly low than its yearly peak, although the distance from the low was 105.01 percent.

Trading activity also remained measurable. Volume reached 1,855,573 shares on October 16, 2026, compared with an average volume of 3,433,892 shares. The session range was USD 0.32 to USD 0.34, while the opening price was USD 0.34.

Valuation and reporting date

Cosmos Health had a market capitalization of USD 33.3 million on October 16, 2026. The trailing price-to-earnings ratio was minus 0.50, and earnings per share stood at minus USD 0.74. No dividend yield was reported in the same market snapshot.

The November 17, 2026 reporting date is the next calendar marker identified for the company. Investing.com also lists the latest release as August 19, 2026, giving the upcoming report a clear quarterly comparison point.

Comparison with peers

COSM: minus 1.52 percent, P/E minus 0.50, market capitalization USD 33.3 million

Pfizer (NYSE, USD): plus 0.48 percent, P/E 39.09, market capitalization USD 168.6 billion

Viatris (Nasdaq, USD): plus 2.39 percent, P/E minus 51.82, market capitalization USD 21.4 billion

Where the stock stands

The combination of a USD 33.3 million market value and a wide USD 0.16 to USD 1.14 yearly range underlines the small-cap profile of Cosmos Health. The next earnings date is therefore the clearest upcoming event for investors tracking whether operating progress can alter the company's current valuation picture.

Cosmos Health stock was last at USD 0.33 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 1.52 percent versus the Nasdaq prior close of October 15, 2026 at USD 0.34.